<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Genetics and Epidemiology</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DB1F3731-FE91-49D8-9CF1-6A9452125A35"><gtr:id>DB1F3731-FE91-49D8-9CF1-6A9452125A35</gtr:id><gtr:firstName>S</gtr:firstName><gtr:surname>Moss</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9000793"><gtr:id>5C4D5DA2-F6A3-47B8-A3A7-EAABB976D5EF</gtr:id><gtr:title>A trial to study the effect on breast cancer mortality of annual mammographic screening starting at age 40</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9000793</gtr:grantReference><gtr:abstractText>At the time this trial began the NHS breast screening programme (NHSBSP) invited women aged 50-64 for screening by mammography every three years, although the upper age limit has now been extended to age 70. At this time results from previous trials had not shown any benefit from screening at younger ages, but none of these trials had been designed to look specifically at the benefit of screening in different age-groups. It is also likely that screening needs to be more frequent in younger women in order to be effective, as cancers may be more difficult to detect and may develop more quickly. 

The aim of this trial is to determine the additional benefit of annual mammographic screening from age 40 in reducing deaths from breast cancer, compared with starting screening from age 50. The trial is taking place in 23 screening units in the UK. A total of 160,000 women aged 
40?41 have been randomly allocated to a study group offered screening, or to a control group who are not invited. All women in both arms are eligible for the NHS Breast Screening Programme which currently invites women for the first time between the ages of 50 and 52</gtr:abstractText><gtr:technicalSummary>The Age Trial is a randomised controlled trial, designed to study the effectiveness of starting mammographic screening from age 40 compared with from age 50 as in the current UK national programme. Women in the intervention arm are offered annual screening by mammography between ages 40 and 48. Both arms are being followed to determine subsequent cancer incidence and mortality. Twenty-three centres, which are all NHSBSP screening units, are participating in the trial. The primary outcome measure will be mortality from breast cancer in the two trial arms. The trial began in 1991, and 160,000 women have been randomised. This application is for funding to complete the fieldwork and for continued follow-up and analysis. An economic study has already been completed, and results on mortality will be combined with these results to inform on the cost effectiveness of screening by mammographs from age 40.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1990-07-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1839110</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Public Health</gtr:department><gtr:description>Modelling the UK age trial : to validate/calibrate five CISNET models for the efficacy of screening women 40-49 years old using data from the UK age trial</gtr:description><gtr:id>0878AF21-6ACA-4AEF-8F8B-0EB1B40225B2</gtr:id><gtr:impact>Wotrk stil in progress</gtr:impact><gtr:outcomeId>56d6d3e26c2f78.03258946-1</gtr:outcomeId><gtr:partnerContribution>Estimation of outcomes of differnt screening protocols</gtr:partnerContribution><gtr:piContribution>Aggregated data from the trial to be used to validate/calibrate existing simulation models</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mammographic density studies</gtr:description><gtr:id>EE4ACC17-4A8F-46EA-8ECE-840C1DB5288E</gtr:id><gtr:impact>PMID 19679547 PMID 19490643 PMID20144221</gtr:impact><gtr:outcomeId>AFBD6C1596F-1</gtr:outcomeId><gtr:piContribution>Provision of data and intellectual input into study design and outputs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>161153</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>AF9F5FFB-D461-4AD0-86E9-EC8EC46FC3FB</gtr:id><gtr:outcomeId>bfTyD9Gfxhe0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>screening age range</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C6E77D43-23E8-4012-88F4-4144CCCC9E6E</gtr:id><gtr:impact>addition to knowledge on appropriate age at which to commence routine breast screening</gtr:impact><gtr:outcomeId>25117EB72FD</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>RCT of mammographic screening from age 40 - first mortality results published 2010, long term follow up results 
currentky being analysed</gtr:description><gtr:id>735E9047-585E-48F2-B7C1-DAC7FE02322C</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>5277ce5bcaaa8</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>mammographic screening in young women</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C7FD58E4-C9EA-4327-A769-88D784CE34A6</gtr:id><gtr:title>False-positive results in the randomized controlled trial of mammographic screening from age 40 (&amp;quot;Age&amp;quot; trial).</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfeb4731bfe22bec46bdccdbbe6053b2"><gtr:id>dfeb4731bfe22bec46bdccdbbe6053b2</gtr:id><gtr:otherNames>Johns LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>mG2G91Xmdqh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0D40D77-A864-4F96-B0CD-6D3D91239C56</gtr:id><gtr:title>International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/948b73570eb55ab4a935b82945b78a2f"><gtr:id>948b73570eb55ab4a935b82945b78a2f</gtr:id><gtr:otherNames>McCormack VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1877-7821</gtr:issn><gtr:outcomeId>56d6d23e913de2.45840031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39EE7B10-F5A4-4E93-ADC7-7C927C2C8C1E</gtr:id><gtr:title>Assessing the amount of unscheduled screening (&amp;quot;contamination&amp;quot;) in the control arm of the UK &amp;quot;Age&amp;quot; Trial.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bac586d5e94bcd347755b8eb35a8c3f3"><gtr:id>bac586d5e94bcd347755b8eb35a8c3f3</gtr:id><gtr:otherNames>Kingston N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>qquCpeoau9n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>185C734F-1B60-4A84-BCD0-BE6538E00FA3</gtr:id><gtr:title>Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5af6b92dd7c47c81760831058e3d14a"><gtr:id>d5af6b92dd7c47c81760831058e3d14a</gtr:id><gtr:otherNames>Moss SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>298D9BED744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F3772E1-3BA8-4F0E-8508-B9FC3169AA7E</gtr:id><gtr:title>Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40-41 years.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e54559295db3d5ddfcd6a90134a2b638"><gtr:id>e54559295db3d5ddfcd6a90134a2b638</gtr:id><gtr:otherNames>Evans AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>7DC1089D262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3269A09-5867-4513-946D-BE174FA92753</gtr:id><gtr:title>Mammographic density and markers of socioeconomic status: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825a89eb1965299d49eb70d0d6cfb1fd"><gtr:id>825a89eb1965299d49eb70d0d6cfb1fd</gtr:id><gtr:otherNames>Aitken Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>Q93HL3xdsou</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DE48629-34A8-4DBC-8B46-913D46C65B08</gtr:id><gtr:title>Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Breast cancer research : BCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffccdca48583fdadd5c4f4f45bfe2385"><gtr:id>ffccdca48583fdadd5c4f4f45bfe2385</gtr:id><gtr:otherNames>Gunsoy NB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1465-5411</gtr:issn><gtr:outcomeId>pm_16070_20_23194032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A19939-DC62-44E9-949C-15640E3D7FAB</gtr:id><gtr:title>Localized fibroglandular tissue as a predictor of future tumor location within the breast.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9f0c1254ae9ee211d57cffc21b58f1e"><gtr:id>c9f0c1254ae9ee211d57cffc21b58f1e</gtr:id><gtr:otherNames>Pinto Pereira SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>pm_16070_20_21693627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95CF065B-6C62-41EE-9579-DFE835E23A4C</gtr:id><gtr:title>Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e54559295db3d5ddfcd6a90134a2b638"><gtr:id>e54559295db3d5ddfcd6a90134a2b638</gtr:id><gtr:otherNames>Evans AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>2A2407D9549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DE167F4-C70E-43D5-99F0-8C507AAD280C</gtr:id><gtr:title>Pathological and mammographic prognostic factors for screen detected cancers in a multi-centre randomised, controlled trial of mammographic screening in women from age 40 to 48 years.</gtr:title><gtr:parentPublicationTitle>Breast (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b7497ce83dc5563fc22321d3040ad11"><gtr:id>2b7497ce83dc5563fc22321d3040ad11</gtr:id><gtr:otherNames>Bennett RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-9776</gtr:issn><gtr:outcomeId>jn5P1M8j9Jo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D345852A-662B-4AAB-8958-5E22D88FE5A4</gtr:id><gtr:title>Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/479c53194f9019dc94c5dcbe277a9129"><gtr:id>479c53194f9019dc94c5dcbe277a9129</gtr:id><gtr:otherNames>Walker K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>F2EC9C482E8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF08DB4-049E-4898-AFD5-4A445761A084</gtr:id><gtr:title>The spatial distribution of radiodense breast tissue: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Breast cancer research : BCR</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9f0c1254ae9ee211d57cffc21b58f1e"><gtr:id>c9f0c1254ae9ee211d57cffc21b58f1e</gtr:id><gtr:otherNames>Pinto Pereira SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-5411</gtr:issn><gtr:outcomeId>8D403023522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A487A487-2697-465F-88A5-5E497AD8F953</gtr:id><gtr:title>Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0be0dc5f962e5c5bb138b5d4546f036"><gtr:id>b0be0dc5f962e5c5bb138b5d4546f036</gtr:id><gtr:otherNames>Moss S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d6d23f150a78.05109221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>152115EE-14B3-426D-89B2-D767CE3966C8</gtr:id><gtr:title>Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance.</gtr:title><gtr:parentPublicationTitle>Journal of medical screening</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfeb4731bfe22bec46bdccdbbe6053b2"><gtr:id>dfeb4731bfe22bec46bdccdbbe6053b2</gtr:id><gtr:otherNames>Johns LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-1413</gtr:issn><gtr:outcomeId>MiJmfDF3ewp</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9000793</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>